Interim Report Second Quarter 2021
NASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENOSTENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2021 – 30.06.2021. The report is attached to this release and is also available on https://stenocare.com/investor-relations/ Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: “Q2 brought clarity to the future of the medical cannabis industry in Denmark. The Danish Pilot Programme for treatment of patients was extended with another four-years, and cultivation/production is permanently legal. This is very good news for both patients and for the